What is he best known for?
The fields of study he is best known for:
Beat W. Schäfer focuses on Cancer research, Gene, Genetics, Pathology and Molecular biology.
In his study, Immunology and Chemotherapy is inextricably linked to Gene expression profiling, which falls within the broad field of Cancer research.
His Gene research incorporates elements of Cell culture, Calcium-binding protein and S100 protein.
Beat W. Schäfer has included themes like Cancer and Cell growth in his Pathology study.
His Molecular biology study combines topics from a wide range of disciplines, such as Carcinogenesis, Candidate Tumor Suppressor Gene, Rhabdomyosarcoma, Alveolar rhabdomyosarcoma and Regulation of gene expression.
His work focuses on many connections between Rhabdomyosarcoma and other disciplines, such as Ectopic expression, that overlap with his field of interest in Cell biology.
His most cited work include:
- The S100 family of EF-hand calcium-binding proteins: functions and pathology. (1031 citations)
- S100 proteins: structure, functions and pathology. (613 citations)
- The MLL recombinome of acute leukemias in 2013 (344 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Cancer research, Molecular biology, Rhabdomyosarcoma, Pathology and Cell biology.
The various areas that he examines in his Cancer research study include Cell culture, Transcription factor, Immunology, Alveolar rhabdomyosarcoma and Sarcoma.
His Molecular biology study integrates concerns from other disciplines, such as Gene expression, Transfection, Complementary DNA, Messenger RNA and Gene.
Gene is a subfield of Genetics that Beat W. Schäfer investigates.
His Pathology research includes themes of Cancer and Metastasis.
The concepts of his Cell biology study are interwoven with issues in Cell and Calcium-binding protein.
He most often published in these fields:
- Cancer research (30.19%)
- Molecular biology (23.11%)
- Rhabdomyosarcoma (17.92%)
What were the highlights of his more recent work (between 2013-2021)?
- Cancer research (30.19%)
- Rhabdomyosarcoma (17.92%)
- Alveolar rhabdomyosarcoma (13.68%)
In recent papers he was focusing on the following fields of study:
His main research concerns Cancer research, Rhabdomyosarcoma, Alveolar rhabdomyosarcoma, Cell biology and Transcription factor.
His Cancer research research is multidisciplinary, incorporating perspectives in Epigenetics, Bromodomain, BRD4, Gene silencing and PI3K/AKT/mTOR pathway.
His work deals with themes such as Insulin-like growth factor 1 receptor, Stem cell, Immunology and Furin, which intersect with Rhabdomyosarcoma.
His work carried out in the field of Alveolar rhabdomyosarcoma brings together such families of science as Carcinogenesis, Phenotype, Kinase and Bioinformatics.
His study in the field of Myogenic differentiation also crosses realms of Block.
His Transcription factor research also works with subjects such as
- Fusion protein which is related to area like Transactivation, DNA-binding domain, PLK1, Phosphorylation and Molecular biology,
- Chromatin and related Regulation of gene expression,
- Pediatric cancer that connect with fields like CRISPR and Pathology,
- Transcription that intertwine with fields like Sp1 transcription factor, MyoD and Myogenesis.
Between 2013 and 2021, his most popular works were:
- The MLL recombinome of acute leukemias in 2017 (231 citations)
- Rhabdomyosarcoma: Current challenges and their implications for developing therapies (41 citations)
- Targeting hedgehog signaling reduces self-renewal in embryonal rhabdomyosarcoma (37 citations)
In his most recent research, the most cited papers focused on:
The scientist’s investigation covers issues in Cancer research, Alveolar rhabdomyosarcoma, Transcription factor, Fusion protein and Cell biology.
His studies deal with areas such as Gene expression, Immunology, Signal transduction, Rhabdomyosarcoma and Kinase as well as Cancer research.
His Gene expression research integrates issues from PI3K/AKT/mTOR pathway and Transcription.
His research in Alveolar rhabdomyosarcoma intersects with topics in Mutation, Loss function, Mutant and Pax genes.
The subject of his Transcription factor research is within the realm of Genetics.
His work in Cell biology addresses issues such as Carcinogenesis, which are connected to fields such as Molecular biology, Hedgehog signaling pathway, GLI1, Hedgehog and Stem cell.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
